Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucitanib + Carboplatin + Etoposide in Untreated ES-SCLC
NCT04254471Phase 3Unknown
- Sponsor
- Haihe
- Start
- Nov 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lucitanib in small cell lung cancer (SCLC), sponsored by Haihe. Status: unknown.
02
Drugs
lucitanib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04254471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254471.